Last reviewed · How we verify
Multicenter Randomized Controlled Trial to Evaluate the Strategy of Primary Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002 Study)
The ADCI 002 trial is a large multicenter phase II-III prospective randomized controlled trial comparing primary surgery versus primary chemotherapy followed by surgery in patients with a resectable signet ring cell gastric adenocarcinoma
Details
| Lead sponsor | University Hospital, Lille |
|---|---|
| Phase | NA |
| Status | RECRUITING |
| Enrolment | 314 |
| Start date | 2012-10 |
| Completion | 2027-11 |
Conditions
- Signet Ring Cell Gastric Adenocarcinoma
Interventions
- peri-operative chemotherapy
- Surgery first
Primary outcomes
- Percentage of patients dead in the 2-years — 2 years
Countries
France